Literature DB >> 18799905

[Prevention of phlebitis caused by vinorelbine chemotherapy in outpatients with breast cancer].

Yukiko Yokota1, Tomoko Suzuki, Takeshi Narahashi, Jun Takizawa, Makoto Kojima, Retsu Shimada.   

Abstract

We studied the prevention of phlebitis in 10 patients who had developed the symptoms after receiving vinorelbine to treat breast cancer at our outpatient chemotherapy clinic from July 2005 to August 2006. Veins proximal to the injection site were warmed using hot compresses during the vinorelbine injection and physiological saline was increased to wash out the drug after the injection from 250 mL to 500 mL in combination to investigate whether the treatment was effective in preventing phlebitis. The severity of phlebitis was significantly decreased after the combined treatment compared with the pre-treatment level (p=0.039). The combination was effective to relieve vascular pain during the injection in all 10 patients, and the number of event occurrences was significantly decreased (p<0.0005). It was also effective to decrease the frequency of vascular pain after patients returned home (p=0.001). The combination of hot compresses and increase of physiological saline for washing out was an effective treatment to prevent phlebitis caused by vinorelbine. The comparison of patient characteristics to find other contributing factors to phlebitis than vinorelbine revealed no association with the number of doses, diameter of the vein to be punctured, or pretreatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799905

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Risk factors for venous irritation in patients receiving vinorelbine: a retrospective study.

Authors:  Yoshihito Morimoto; Kumika Miyawaki; Reisuke Seki; Kazuhiro Watanabe; Masayoshi Hirohara; Takao Shinohara
Journal:  J Pharm Health Care Sci       Date:  2018-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.